Halifax-based Immunovaccine is on the verge of being the next big thing in the fight against cancer—or it could fall just short of commercialization
Halifax-based Immunovaccine is on the verge of being the next big thing in the fight against cancer—or it could fall just short of commercialization
Copyright © 2021 Atlantic Business Magazine